☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware |
94-3125814 | |
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Common Stock ($0.001 par value) |
IVAC |
The Nasdaq Stock Market LLC (Nasdaq) Global Select |
Large accelerated filer |
☐ |
Accelerated filer |
☒ | |||
Non-accelerated filer |
☐ |
Smaller reporting company |
☒ | |||
Emerging growth company |
☐ |
No. |
Page |
|||||
Item 1. |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
6 |
||||||
7 |
||||||
Item 2. |
20 |
|||||
Item 3. |
27 |
|||||
Item 4. |
27 |
|||||
Item 1. |
28 |
|||||
Item 1A. |
28 |
|||||
Item 2. |
34 |
|||||
Item 3. |
34 |
|||||
Item 4. |
34 |
|||||
Item 5. |
34 |
|||||
Item 6. |
35 |
|||||
36 |
Item 1. |
Financial Statements |
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
(Unaudited) | ||||||||
(In thousands, except per share amounts) | ||||||||
Net revenues |
$ | 4,445 | $ | 9,238 | ||||
Cost of net revenues |
3,722 | 7,104 | ||||||
|
|
|
|
|||||
Gross profit |
723 | 2,134 | ||||||
Operating expenses: |
||||||||
Research and development |
4,160 | 3,365 | ||||||
Selling, general and administrative |
4,249 | 4,334 | ||||||
|
|
|
|
|||||
Total operating expenses |
8,409 | 7,699 | ||||||
|
|
|
|
|||||
Loss from operations |
(7,686 | ) | (5,565 | ) | ||||
Interest income and other income (expense), net |
(8 | ) | 29 | |||||
|
|
|
|
|||||
Loss from continuing operations before provision for income taxes |
(7,694 | ) | (5,536 | ) | ||||
Provision for income taxes |
26 | 32 | ||||||
|
|
|
|
|||||
Net loss from continuing operations |
(7,720 | ) | (5,568 | ) | ||||
|
|
|
|
|||||
Net loss from discontinued operations, net of taxes |
(135 | ) | (936 | ) | ||||
|
|
|
|
|||||
Net loss |
(7,855 | ) | (6,504 | ) | ||||
|
|
|
|
|||||
Net loss per share: |
||||||||
Basic and diluted – continuing operations |
$ | (0.31 | ) | $ | (0.23 | ) | ||
Basic and diluted – discontinued operations |
$ | (0.01 | ) | $ | (0.04 | ) | ||
Basic and diluted – net loss |
$ | (0.32 | ) | $ | (0.27 | ) | ||
Weighted average common shares outstanding: |
||||||||
Basic and diluted |
24,800 | 24,033 |
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
(Unaudited) |
||||||||
(In thousands) |
||||||||
Net loss |
$ | (7,855 | ) | $ | (6,504 | ) | ||
|
|
|
|
|||||
Other comprehensive loss, before tax: |
||||||||
Change in unrealized net gain (loss) on available-for-sale |
(174 | ) | (20 | ) | ||||
Foreign currency translation losses |
(33 | ) | (68 | ) | ||||
|
|
|
|
|||||
Other comprehensive loss, before tax |
(207 | ) | (88 | ) | ||||
|
|
|
|
|||||
Income tax provision related to items in other comprehensive loss |
— | — | ||||||
|
|
|
|
|||||
Other comprehensive loss, net of tax |
(207 | ) | (88 | ) | ||||
|
|
|
|
|||||
Comprehensive loss |
$ | (8,062 | ) | $ | (6,592 | ) | ||
|
|
|
|
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
(Unaudited) |
||||||||
(In thousands) |
||||||||
Operating activities |
||||||||
Net loss |
$ | (7,855 | ) | $ | (6,504 | ) | ||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
||||||||
Depreciation and amortization |
445 | 791 | ||||||
Net amortization (accretion) of investment premiums and discounts |
17 | 33 | ||||||
Equity-based compensation |
(1,036 | ) | 968 | |||||
Straight-line rent adjustment and amortization of lease incentives |
(198 | ) | (115 | ) | ||||
Loss on disposal of fixed assets |
1,453 | — |
||||||
Deferred income taxes |
(6 | ) | (40 | ) | ||||
Changes in operating assets and liabilities |
3,130 | 7,399 | ||||||
|
|
|
|
|||||
Total adjustments |
3,805 | 9,036 | ||||||
|
|
|
|
|||||
Net cash provided by (used in) operating activities |
(4,050 | ) | 2,532 | |||||
Investing activities |
||||||||
Purchases of investments |
(6,525 | ) | (5,962 | ) | ||||
Proceeds from sales and maturities of investments |
5,634 | 6,140 | ||||||
Purchases of leasehold improvements and equipment |
(618 | ) | (243 | ) | ||||
|
|
|
|
|||||
Net cash used in investing activities |
(1,509 | ) | (65 | ) | ||||
Financing activities |
||||||||
Proceeds from issuance of common stock |
1,033 | 1,096 | ||||||
Taxes paid related to net share settlement |
(135 | ) | (20 | ) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
898 | 1,076 | ||||||
|
|
|
|
|||||
Effect of exchange rate changes on cash and cash equivalents |
(33 | ) | (68 | ) | ||||
|
|
|
|
|||||
Net increase (decrease) in cash, cash equivalents and restricted cash |
(4,694 | ) | 3,475 | |||||
Cash, cash equivalents and restricted cash at beginning of period |
103,514 | 30,128 | ||||||
|
|
|
|
|||||
Cash, cash equivalents and restricted cash at end of period |
$ | 98,820 | $ | 33,603 | ||||
|
|
|
|
1. |
Description of Business and Basis of Presentation |
2. |
Divestiture and Discontinued Operations |
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
(in thousands) |
||||||||
Net revenues: |
||||||||
Systems and components |
$ | — | $ | 3,822 | ||||
Technology development |
— | 3,181 | ||||||
|
|
|
|
|||||
Total net revenues |
— | 7,003 | ||||||
Cost of net revenues: |
||||||||
Systems and components |
— | 2,860 | ||||||
Technology development |
— | 3,223 | ||||||
|
|
|
|
|||||
Total cost of net revenues |
— | 6,083 | ||||||
Gross profit |
— | 920 | ||||||
Operating expenses: |
||||||||
Research and development |
— | 260 | ||||||
Selling, general and administrative |
135 | 1,596 | ||||||
|
|
|
|
|||||
Total operating expenses |
135 | 1,856 | ||||||
|
|
|
|
|||||
Operating loss – discontinued operations |
(135 | ) | (936 | ) | ||||
Other income (expense) – discontinued operations |
— | — | ||||||
|
|
|
|
|||||
Loss from discontinued operations before provision for (benefit from) income taxes |
(135 | ) | (936 | ) | ||||
Provision for (benefit from) income taxes |
— | — | ||||||
|
|
|
|
|||||
Net loss from discontinued operations net of taxes |
$ | (135 | ) | $ | (936 | ) | ||
|
|
|
|
Three Months Ended |
||||||||
April 2, |
April 3, |
|||||||
2022 |
2021 |
|||||||
(in thousands) |
||||||||
Depreciation and amortization |
$ | — | $ | 285 | ||||
Equity-based compensation |
$ | (330 | ) | $ | 272 | |||
Purchase of leasehold improvements and equipment |
$ | — | $ | 73 |
3. |
Revenue |
Three Months Ended April 2, 2022 |
Three Months Ended April 3, 2021 |
|||||||||||||||||||||||||||||||||||
(in thousands) |
||||||||||||||||||||||||||||||||||||
HDD |
DCP |
PV |
Total |
HDD |
DCP |
PV |
ASP |
Total |
||||||||||||||||||||||||||||
Systems, upgrades and spare parts |
$ | 3,123 | $ | — | $ | 53 | $ | 3,176 | $ | 3,585 | $ | — | $ | 111 | $ | 3,850 | $ | 7,546 | ||||||||||||||||||
Field service |
1,263 | — | 6 | 1,269 | 1,636 | 14 | 42 | — | 1,692 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Total TFE net revenues |
$ | 4,386 | $ | — | $ | 59 | $ | 4,445 | $ | 5,221 | $ | 14 | $ | 153 | $ | 3,850 | $ | 9,238 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
(in thousands) |
||||||||
United States |
$ | 294 | $ | 367 | ||||
Asia |
4,151 | 5,021 | ||||||
Europe |
— | 3,850 | ||||||
|
|
|
|
|||||
Total net revenues |
$ | 4,445 | $ | 9,238 | ||||
|
|
|
|
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
(in thousands) |
||||||||
Products transferred at a point in time |
$ | 4,445 | $ | 9,238 | ||||
Products and services transferred over time |
— | — | ||||||
|
|
|
|
|||||
Total net revenues |
$ | 4,445 | $ | 9,238 | ||||
|
|
|
|
April 2, 2022 |
January 1, 2022 |
Three Months Change |
||||||||||
(in thousands) |
||||||||||||
Contract assets: |
||||||||||||
Accounts receivable, unbilled |
$ | — | $ | 99 | $ | (99 | ) | |||||
|
|
|
|
|
|
|||||||
Contract liabilities: |
||||||||||||
Deferred revenue |
$ | 55 | $ | 65 | $ | (10 | ) | |||||
Customer advances |
15,320 | 2,107 | 13,213 | |||||||||
|
|
|
|
|
|
|||||||
$ | 15,375 | $ | 2,172 | $ | 13,203 | |||||||
|
|
|
|
|
|
4. |
Inventories |
April 2, |
January 1, |
|||||||
2022 |
2022 |
|||||||
(in thousands) |
||||||||
Raw materials |
$ | 6,346 | $ | 5,323 | ||||
Work-in-progress |
2,562 | 468 | ||||||
|
|
|
|
|||||
$ | 8,908 | $ | 5,791 | |||||
|
|
|
|
5. |
Equity-Based Compensation |
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
(In thousands) |
||||||||
Equity-based compensation by type of award: |
||||||||
Stock options |
$ | (171 | ) | $ | 75 | |||
RSUs |
(728 | ) | 543 | |||||
ESPP purchase rights |
(137 | ) | 350 | |||||
|
|
|
|
|||||
Total equity-based compensation |
$ | (1,036 | ) | $ | 968 |
(a) | A reversal of $1.3 million in equity-based compensation expense related to forfeitures of awards due to our reduction in workforce and a $37,000 benefit related to the modification of certain stock-based awards for the three months ended April 2, 2022. (See Note |
(b) | Equity-based compensation reported in discontinued operations of ($330,000) and $272,000 for the three months ended April |
Shares |
Weighted-Average Exercise Price |
|||||||
Options outstanding at January 1, 2022 |
1,457,587 | $ | 6.55 | |||||
Options granted |
— | $ | — | |||||
Options cancelled and forfeited |
(102,152 | ) | $ | 5.43 | ||||
Options exercised |
(65,563 | ) | $ | 5.06 | ||||
|
|
|
|
|||||
Options outstanding at April 2, 2022 |
1,289,872 | $ | 6.72 | |||||
|
|
|||||||
Options exercisable at April 2, 2022 |
1,223,472 | $ | 6.79 |
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
ESPP Purchase Rights: |
||||||||
Weighted-average fair value of grants per share |
$ | 1.85 | $ | 2.69 | ||||
Expected volatility |
60.36 | % | 58.56 | % | ||||
Risk-free interest rate |
0.98 | % | 0.08 | % | ||||
Expected term of purchase rights (in years) |
1.2 | 1.0 | ||||||
Dividend yield |
None | None |
Shares |
Weighted-Average Grant Date Fair Value |
|||||||
Non-vested RSUs at January 1, 2022 |
1,033,436 | $ | 5.59 | |||||
Granted |
300,928 | $ | 5.11 | |||||
Vested |
(66,704 | ) | $ | 5.45 | ||||
Cancelled and forfeited |
(533,199 | ) | $ | 5.65 | ||||
|
|
|||||||
Non-vested RSUs at April 2, 2022 |
734,461 | $ | 5.37 | |||||
|
|
6. |
Warranty |
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
(in thousands) |
||||||||
Opening balance |
$ | 346 | $ | 480 | ||||
Expenditures incurred under warranties |
(171 | ) | (153 | ) | ||||
Expenditures incurred under warranties included in discontinued operations |
— | (46 | ) | |||||
Accruals for product warranties issued during the reporting period |
36 | 255 | ||||||
Accruals for product warranties issued during the reporting period included in discontinued operations |
— | 20 | ||||||
Adjustments to previously existing warranty accruals |
38 | (10 | ) | |||||
Adjustments to previously existing warranty accruals included in discontinued operations |
— | 44 | ||||||
|
|
|
|
|||||
Closing balance |
$ | 249 | $ | 590 | ||||
|
|
|
|
April 2 2022 |
January 1 2022 |
|||||||
(in thousands) |
||||||||
Other accrued liabilities |
$ | 219 | $ | 301 | ||||
Other long-term liabilities |
30 | 45 | ||||||
|
|
|
|
|||||
Total warranty provision |
$ | 249 | $ | 346 | ||||
|
|
|
|
7. |
Guarantees |
8. |
Cash, Cash Equivalents and Investments |
April 2, 2022 |
||||||||||||||||
Amortized Cost |
Unrealized Holding Gains |
Unrealized Holding Losses |
Fair Value |
|||||||||||||
(in thousands) |
||||||||||||||||
Cash and cash equivalents: |
||||||||||||||||
Cash |
$ | 93,662 | $ | — | $ | — | $ | 93,662 | ||||||||
Money market funds |
3,042 | — | — | 3,042 | ||||||||||||
Certificates of deposit |
500 | — | — | 500 | ||||||||||||
Commercial paper |
300 | — | — | 300 | ||||||||||||
U.S. treasury securities |
530 | — | — | 530 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents |
$ | 98,034 | $ | — | $ | — | $ | 98,034 | ||||||||
Short-term investments: |
||||||||||||||||
Certificates of deposit |
$ | 2,750 | $ | — | $ | 11 | $ | 2,739 | ||||||||
Commercial paper |
898 | — | — | 898 | ||||||||||||
Corporate bonds and medium-term notes |
3,293 | — | 27 | 3,266 | ||||||||||||
Municipal bonds |
145 | — | 2 | 143 | ||||||||||||
U.S. treasury securities |
1,909 | — | 14 | 1,895 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments |
$ | 8,995 | $ | — | $ | 54 | $ | 8,941 | ||||||||
Long-term investments: |
||||||||||||||||
Asset backed securities |
$ | 3,745 | $ | — | $ | 30 | $ | 3,715 | ||||||||
Corporate bonds and medium-term notes |
1,718 | — | 22 | 1,696 | ||||||||||||
Municipal bonds |
347 | — | 2 | 345 | ||||||||||||
U.S. treasury securities |
3,747 | — | 96 | 3,651 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total long-term investments |
$ | 9,557 | $ | — | $ | 150 | $ | 9,407 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, and investments |
$ | 116,586 | $ | — | $ | 204 | $ | 116,382 | ||||||||
|
|
|
|
|
|
|
|
January 1, 2022 |
||||||||||||||||
Amortized Cost |
Unrealized Holding Gains |
Unrealized Holding Losses |
Fair Value |
|||||||||||||
(in thousands) |
||||||||||||||||
Cash and cash equivalents: |
||||||||||||||||
Cash |
$ | 102,494 | $ | — | $ | — | $ | 102,494 | ||||||||
Money market funds |
234 | — | — | 234 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents |
$ | 102,728 | $ | — | $ | — | $ | 102,728 | ||||||||
Short-term investments: |
||||||||||||||||
Certificates of deposit |
$ | 4,300 | $ | — | $ | — | $ | 4,300 | ||||||||
Commercial paper |
400 | — | — | 400 | ||||||||||||
Corporate bonds and medium-term notes |
2,916 | — | 3 | 2,913 | ||||||||||||
Municipal bonds |
700 | — | — | 700 | ||||||||||||
U.S. treasury securities |
1,910 | — | 2 | 1,908 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments |
$ | 10,226 | $ | — | $ | 5 | $ | 10,221 | ||||||||
Long-term investments: |
||||||||||||||||
Asset backed securities |
$ | 2,040 | $ | — | $ | 3 | $ | 2,037 | ||||||||
Certificates of deposit |
500 | — | 3 | 497 | ||||||||||||
Corporate bonds and medium-term notes |
1,521 | — | 6 | 1,515 | ||||||||||||
Municipal bonds |
145 | — | 1 | 144 | ||||||||||||
U.S. treasury securities |
3,246 | — | 12 | 3,234 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total long-term investments |
$ | 7,452 | $ | — | $ | 25 | $ | 7,427 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, and investments |
$ | 120,406 | $ | — | $ | 30 | $ | 120,376 | ||||||||
|
|
|
|
|
|
|
|
Amortized Cost |
Fair Value |
|||||||
(in thousands) |
||||||||
Due in one year or less |
$ | 13,367 | $ | 13,313 | ||||
Due after one through five years |
9,557 | 9,407 | ||||||
|
|
|
|
|||||
$ | 22,924 | $ | 22,720 | |||||
|
|
|
|
April 2, 2022 |
||||||||||||||||
In Loss Position for Less than 12 Months |
In Loss Position for Greater than 12 Months |
|||||||||||||||
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
|||||||||||||
(in thousands) |
||||||||||||||||
Asset backed securities |
$ | 3,715 | $ | 30 | $ | — | $ | — | ||||||||
Certificates of deposit |
2,739 | 11 | — | — | ||||||||||||
Corporate bonds and medium-term notes |
4,460 | 44 | 502 | 5 | ||||||||||||
Municipal bonds |
488 | 4 | — | — | ||||||||||||
U.S. treasury securities |
5,546 | 110 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 16,948 | $ | 199 | $ | 502 | $ | 5 | |||||||||
|
|
|
|
|
|
|
|
Fair Value Measurements at April 2, 2022 |
||||||||||||
Total |
Level 1 |
Level 2 |
||||||||||
(in thousands) |
||||||||||||
Recurring fair value measurements: |
||||||||||||
Investment securities |
||||||||||||
Money market funds |
$ | 3,042 | $ | 3,042 | $ | — | ||||||
U.S. treasury securities |
6,076 | 6,076 | — | |||||||||
Asset backed securities |
3,715 | — | 3,715 | |||||||||
Certificates of deposit |
3,239 | — | 3,239 | |||||||||
Commercial paper |
1,198 | — | 1,198 | |||||||||
Corporate bonds and medium-term notes |
4,962 | — | 4,962 | |||||||||
Municipal bonds |
488 | — | 488 | |||||||||
|
|
|
|
|
|
|||||||
Total recurring fair value measurements |
$ | 22,720 | $ | 9,118 | $ | 13,602 | ||||||
|
|
|
|
|
|
9. |
Derivative Instruments |
Notional Amounts |
Derivative Liabilities |
Derivative Assets |
||||||||||||||||||||||
Derivative Instrument |
April 2, 2022 |
January 1, 2022 |
April 2, 2022 |
January 1, 2022 |
||||||||||||||||||||
Balance Sheet Line |
Fair Value |
Balance Sheet Line |
Fair Value |
|||||||||||||||||||||
(in thousands) |
||||||||||||||||||||||||
Undesignated Hedges: |
||||||||||||||||||||||||
Forward Foreign Currency Contracts |
$ | 1,179 | 815 | (b ) |
$ | — | (a ) |
$ | 1 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Total Hedges |
$ | 1,179 | 815 | $ | — | $ | 1 | |||||||||||||||||
|
|
|
|
|
|
|
|
Three Months Ended April 2, 2022 |
||||||||||||||||||||
Common Stock and Additional Paid-in Capital |
Treasury Stock |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
Total Stockholders’ Equity |
||||||||||||||||
Balance at January 1, 2022 |
$ | 199,098 | $ | (29,551 | ) | $ | 578 | $ | (36,110 | ) | $ | 134,015 | ||||||||
Common stock issued under employee plans |
1,033 | — | — | — | 1,033 | |||||||||||||||
Shares withheld for net share settlement of RSUs |
(135 | ) | — | — | — | (135 | ) | |||||||||||||
Equity-based compensation expense |
(1,036 | ) | — | — | — | (1,036 | ) | |||||||||||||
Net loss |
— | — | — | (7,855 | ) | (7,855 | ) | |||||||||||||
Other comprehensive loss |
— | — | (207 | ) | — | (207 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at April 2, 2022 |
$ | 198,960 | $ | (29,551 | ) | $ | 371 | $ | (43,965 | ) | $ | 125,815 | ||||||||
Three Months Ended April 3, 2021 |
||||||||||||||||||||
Common Stock and Additional Paid-in Capital |
Treasury Stock |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
Total Stockholders’ Equity |
||||||||||||||||
Balance at January 2, 2021 |
$ | 193,197 | $ | (29,551 | ) | $ | 640 | $ | (62,730 | ) | $ | 101,556 | ||||||||
Common stock issued under employee plans |
1,243 | — | — | — | 1,243 | |||||||||||||||
Shares withheld for net share settlement of RSUs |
(20 | ) | — | — | — | (20 | ) | |||||||||||||
Equity-based compensation expense |
968 | — | — | — | 968 | |||||||||||||||
Net loss |
— | — | — | (6,504 | ) | (6,504 | ) | |||||||||||||
Other comprehensive loss |
— | — | (88 | ) | — | (88 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at April 3, 2021 |
$ | 195,388 | $ | (29,551 | ) | $ | 552 | $ | (69,234 | ) | $ | 97,155 |
Three Months Ended |
||||||||||||||||||||||||
April 2, 2022 |
April 3, 2021 |
|||||||||||||||||||||||
Foreign currency |
Unrealized holding gains (losses) on available-for-sale investments |
Total |
Foreign currency |
Unrealized holding gains (losses) on available-for-sale investments |
Total |
|||||||||||||||||||
(in thousands) |
||||||||||||||||||||||||
Beginning balance |
$ | 608 | $ | (30 | ) | $ | 578 | $ | 602 | $ | 38 | $ | 640 | |||||||||||
Other comprehensive income (loss) before reclassification |
(33 | ) | (174 | ) | (207 | ) | (68 | ) | (20 | ) | (88 | ) | ||||||||||||
Amounts reclassified from other comprehensive income (loss) |
— | — | — | — | — | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net current-period other comprehensive income (loss) |
(33 | ) | (174 | ) | (207 | ) | (68 | ) | (20 | ) | (88 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Ending balance |
$ | 575 | $ | (204 | ) | $ | 371 | $ | 534 | $ | 18 | $ | 552 | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
11. |
Net Loss Per Share |
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
(in thousands) |
||||||||
Net loss from continuing operations |
$ | (7,720 | ) | $ | (5,568 | ) | ||
Net loss from discontinued operations, net of tax |
(135 | ) | (936 | ) | ||||
|
|
|
|
|||||
Net loss |
$ | (7,855 | ) | $ | (6,504 | ) | ||
|
|
|
|
|||||
Weighted-average shares – basic |
24,800 | 24,033 | ||||||
Effect of dilutive potential common shares |
— | — | ||||||
|
|
|
|
|||||
Weighted-average shares – diluted |
24,800 | 24,033 | ||||||
|
|
|
|
|||||
Basic and diluted net loss per share: |
||||||||
Continuing operations |
$ | (0.31 | ) | $ | (0.23 | ) | ||
|
|
|
|
|||||
Discontinued operations |
$ | (0.01 | ) | $ | (0.04 | ) | ||
|
|
|
|
|||||
Net loss per share |
$ | (0.32 | ) | $ | (0.27 | ) | ||
|
|
|
|
12. |
Income Taxes |
13. |
Restructuring and Other Costs, Net |
Employee Termination Costs |
||||
(in thousands) |
||||
Balance at January 1, 2022 |
$ | — | ||
Provision for restructuring charges under the 2022 Cost Reduction Plan |
1,232 | |||
Cash payments made |
(757 | ) | ||
Non-cash utilization (a) |
37 | |||
|
|
|||
Balance at April 2, 2022 (b) |
$ | 512 | ||
|
|
Employee Termination Costs |
Other Exit Costs |
Total |
||||||||||
(in thousands) |
||||||||||||
Balance at January 1, 2022 |
$ | 358 | $ | 665 | $ | 1,023 | ||||||
Provision for restructuring charges associated with Photonics divestiture (a) |
112 | 2 | 114 | |||||||||
Cash payments made |
(137 | ) | (128 | ) | (265 | ) | ||||||
Non-cash utilization (b) |
(75 | ) | — | (75 | ) | |||||||
|
|
|
|
|
|
|||||||
Balance at April 2, 2022 |
$ | 258 | (c) | $ | 539 | $ | 797 | |||||
|
|
|
|
|
|
Three Months Ended April 3, 2021 |
||||
(in thousands) |
||||
Beginning balance |
$ | — | ||
Provision for restructuring reserves |
43 | |||
Cash payments made |
(43 | ) | ||
|
|
|||
Ending balance |
$ | — | ||
|
|
14. |
Commitments and Contingencies |
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Three Months Ended |
||||||||||||
April 3, 2021 |
April 3, 2021 |
Change over prior period |
||||||||||
(In thousands, except percentages and per share amounts) |
||||||||||||
Net revenues |
$ | 4,445 | $ | 9,238 | $ | (4,793 | ) | |||||
Gross profit |
$ | 723 | $ | 2,134 | $ | (1,411 | ) | |||||
Gross margin percent |
16.3 | % | 23.1 | % | (6.8) points | |||||||
Loss from operations |
$ | (7,686 | ) | $ | (5,565 | ) | $ | (2,121 | ) | |||
Net loss from continuing operations |
$ | (7,720 | ) | $ | (5,568 | ) | $ | (2,152 | ) | |||
Net loss from discontinued operations, net of taxes |
$ | (135 | ) | $ | (936 | ) | $ | 801 | ||||
Net loss |
$ | (7,855 | ) | $ | (6,504 | ) | $ | (1,351 | ) | |||
Net loss per diluted share |
$ | (0.32 | ) | $ | (0.27 | ) | $ | (0.05 | ) |
Three Months Ended |
||||||||||||
April 2, 2022 |
April 3, 2021 |
Change over prior period |
||||||||||
(In thousands) |
||||||||||||
Total net revenues |
$ | 4,445 | $ | 9,238 | $ | (4,793 | ) | |||||
|
|
|
|
|
|
April 2, 2022 |
January 1, 2022 |
April 3, 2021 |
||||||||||
(In thousands) |
||||||||||||
Total backlog |
$ | 87,162 | $ | 24,725 | $ | 4,221 | ||||||
|
|
|
|
|
|
Three Months Ended |
||||||||
April 2, 2022 |
April 3, 2021 |
|||||||
(in thousands) |
||||||||
United States |
$ | 294 | $ | 367 | ||||
Asia |
4,151 | 5,021 | ||||||
Europe |
— | 3,850 | ||||||
|
|
|
|
|||||
Total net revenues |
$ | 4,445 | $ | 9,238 | ||||
|
|
|
|
Three Months Ended |
||||||||||||
April 2, 2022 |
April 3, 2021 |
Change over prior period |
||||||||||
(In thousands, except percentages) |
||||||||||||
TFE gross profit |
$ | 723 | $ | 2,134 | $ | (1,411 | ) | |||||
% of TFE net revenues |
16.3 | % | 23.1 | % |
Three Months Ended |
||||||||||||
April 2, 2022 |
April 3, 2021 |
Change over prior period |
||||||||||
(In thousands) |
||||||||||||
Research and development expense |
$ | 4,160 | $ | 3,365 | $ | 795 |
Three Months Ended |
||||||||||||
April 2, 2022 |
April 3, 2021 |
Change over prior period |
||||||||||
(In thousands) |
||||||||||||
Selling, general and administrative expense |
$ | 4,249 | $ | 4,334 | $ | (85 | ) |
Three Months Ended |
||||||||||||
April 3, 2021 |
April 3, 2021 |
Change over prior period |
||||||||||
(In thousands) |
||||||||||||
Interest income and other income (expense), net |
$ | (8 | ) | $ | 29 | $ | (37 | ) |
Three Months Ended |
||||||||||||
April 2, 2022 |
April 3, 2021 |
Change over prior period |
||||||||||
(In thousands) |
||||||||||||
Income tax provision |
$ | 26 | $ | 32 | $ | (6 | ) |
Three Months Ended |
||||||||||||
April 2, 2022 |
April 3, 2021 |
Change over prior period |
||||||||||
(In thousands) |
||||||||||||
Loss from discontinued operations, net of taxes |
$ | 135 | $ | 936 | $ | (801 | ) |
April 2, 2022 |
January 2, 2021 |
|||||||
(In thousands) |
||||||||
Cash and cash equivalents |
$ | 98,034 | $ | 102,728 | ||||
Restricted cash |
786 | 786 | ||||||
Short-term investments |
8,941 | 10,221 | ||||||
Long-term investments |
9,407 | 7,427 | ||||||
|
|
|
|
|||||
Total cash, cash equivalents, restricted cash and investments |
$ | 117,168 | $ | 121,162 | ||||
|
|
|
|
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds |
Item 3. |
Defaults upon Senior Securities |
Item 4. |
Mine Safety Disclosures |
Item 5. |
|